SCHEMBL7456642

SCHEMBL7456642

Nc1cnccc1C(=O)N1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 4/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
KDM6B O15054 1/20 0.56
KDM4A O75164 1/20 0.56
MAPT P10636 1/20 0.56
THRB P10828 1/20 0.56
KDM4D Q6B0I6 1/20 0.56
KDM4C Q9H3R0 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
GLA P06280 1/20 0.50
GAA P10253 1/20 0.50
CYP2C9 P11712 2/20 0.43
HPGD P15428 4/20 0.43
L3MBTL3 Q96JM7 1/20 0.43
HDAC1 Q13547 3/20 0.42
HDAC2 Q92769 3/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15402417 0.97 ALDH1A1 (0.56) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL16115677 0.81 KDM4E (0.46) ALDH1A1KDM4EKMT2AMAPTGAA
SCHEMBL15401990 0.81 KDM4E (0.53) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL10272980 0.80 GAA (0.47) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL17438763 0.80 KDM4E (0.49) ALDH1A1KDM4EKMT2AMAPTGAA
SCHEMBL17438482 0.80 KDM4E (0.45) ALDH1A1KDM4EKMT2AMAPTGAA
SCHEMBL15402054 0.80 KDM4E (0.51) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL15402398 0.79 ALDH1A1 (0.47) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL19372357 0.79 KDM4E (0.47) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL527577 0.79 TSHR (0.49) ALDH1A1KDM4EKMT2AMEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US claimed
US-8623866-B2 2014-01-07 US claimed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP claimed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A ALDH1A1 271/4885KDM4E 2322/4885L3MBTL1 3429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.